TRPV1 modulator that does not cause hyperthermia in rats

[1]  Mark J. Rose,et al.  Pharmacological blockade of the vanilloid receptor TRPV1 elicits marked hyperthermia in humans , 2008, PAIN.

[2]  P. Chakrabarti,et al.  Design and synthesis of peripherally restricted transient receptor potential vanilloid 1 (TRPV1) antagonists. , 2008, Journal of medicinal chemistry.

[3]  J. Treanor,et al.  Repeated Administration of Vanilloid Receptor TRPV1 Antagonists Attenuates Hyperthermia Elicited by TRPV1 Blockade , 2007, Journal of Pharmacology and Experimental Therapeutics.

[4]  N. Chen,et al.  Novel vanilloid receptor-1 antagonists: 2. Structure-activity relationships of 4-oxopyrimidines leading to the selection of a clinical candidate. , 2007, Journal of medicinal chemistry.

[5]  J. Treanor,et al.  Novel vanilloid receptor-1 antagonists: 3. The identification of a second-generation clinical candidate with improved physicochemical and pharmacokinetic properties. , 2007, Journal of medicinal chemistry.

[6]  A. Szallasi,et al.  The vanilloid receptor TRPV1: 10 years from channel cloning to antagonist proof-of-concept , 2007, Nature Reviews Drug Discovery.

[7]  P. Blumberg,et al.  Antinociceptive Pharmacology of N-(4-Chlorobenzyl)-N′-(4-hydroxy-3-iodo-5-methoxybenzyl) Thiourea, a High-Affinity Competitive Antagonist of the Transient Receptor Potential Vanilloid 1 Receptor , 2007, Journal of Pharmacology and Experimental Therapeutics.

[8]  J. Treanor,et al.  The Vanilloid Receptor TRPV1 Is Tonically Activated In Vivo and Involved in Body Temperature Regulation , 2007, The Journal of Neuroscience.

[9]  N. Gavva,et al.  The TRPV1 receptor and nociception. , 2006, Seminars in cell & developmental biology.

[10]  Daniel J. Levitin,et al.  Social Modulation of Pain as Evidence for Empathy in Mice , 2006, Science.

[11]  E. Pintér,et al.  Involvement of transient receptor potential vanilloid 1 in the vascular and hyperalgesic components of joint inflammation. , 2005, Arthritis & Rheumatism.

[12]  A. Gomtsyan,et al.  A-425619 [1-Isoquinolin-5-yl-3-(4-trifluoromethyl-benzyl)-urea], a Novel Transient Receptor Potential Type V1 Receptor Antagonist, Relieves Pathophysiological Pain Associated with Inflammation and Tissue Injury in Rats , 2005, Journal of Pharmacology and Experimental Therapeutics.

[13]  Mark H. Norman,et al.  AMG 9810 [(E)-3-(4-t-Butylphenyl)-N-(2,3-dihydrobenzo[b][1,4] dioxin-6-yl)acrylamide], a Novel Vanilloid Receptor 1 (TRPV1) Antagonist with Antihyperalgesic Properties , 2005, Journal of Pharmacology and Experimental Therapeutics.

[14]  N. Carruthers,et al.  Selective Blockade of the Capsaicin Receptor TRPV1 Attenuates Bone Cancer Pain , 2005, The Journal of Neuroscience.

[15]  S. McMahon,et al.  Acid-Induced Pain and Its Modulation in Humans , 2004, The Journal of Neuroscience.

[16]  P. Anand,et al.  Increased capsaicin receptor TRPV1 nerve fibres in the inflamed human oesophagus , 2004, European journal of gastroenterology & hepatology.

[17]  J. Pomonis,et al.  N-(4-Tertiarybutylphenyl)-4-(3-cholorphyridin-2-yl)tetrahydropyrazine -1(2H)-carbox-amide (BCTC), a Novel, Orally Effective Vanilloid Receptor 1 Antagonist with Analgesic Properties: II. In Vivo Characterization in Rat Models of Inflammatory and Neuropathic Pain , 2003, Journal of Pharmacology and Experimental Therapeutics.

[18]  P. McIntyre,et al.  The VR1 Antagonist Capsazepine Reverses Mechanical Hyperalgesia in Models of Inflammatory and Neuropathic Pain , 2003, Journal of Pharmacology and Experimental Therapeutics.

[19]  S. Teague,et al.  Functional Properties of the High-Affinity TRPV1 (VR1) Vanilloid Receptor Antagonist (4-Hydroxy-5-iodo-3-methoxyphenylacetate ester) Iodo-Resiniferatoxin , 2002, Journal of Pharmacology and Experimental Therapeutics.

[20]  C. Woolf,et al.  p38 MAPK Activation by NGF in Primary Sensory Neurons after Inflammation Increases TRPV1 Levels and Maintains Heat Hyperalgesia , 2002, Neuron.

[21]  Vincent J. Dupriez,et al.  Adaptation of Aequorin Functional Assay to High Throughput Screening , 2002, Journal of biomolecular screening.

[22]  S. Bevan,et al.  Pharmacological differences between the human and rat vanilloid receptor 1 (VR1) , 2001, British journal of pharmacology.

[23]  S. Bingham,et al.  Vanilloid receptor-1 is essential for inflammatory thermal hyperalgesia , 2000, Nature.

[24]  A I Basbaum,et al.  Impaired nociception and pain sensation in mice lacking the capsaicin receptor. , 2000, Science.

[25]  P. Blumberg,et al.  Vanilloid (Capsaicin) receptors and mechanisms. , 1999, Pharmacological reviews.